Zoledronate-Induced Large Vessel Vasculitis Diagnosed by PET/CT

Zoledronate-Induced Large Vessel Vasculitis Diagnosed by PET/CT

Bisphosphonates remain a first-line treatment for osteoporosis. The most-widely used is zoledronate, which is well tolerated by most patients, but may rarely cause acute inflammatory reactions, which resemble those of large vessel vasculitis (LVV). We report a third case of LVV associated with zoled...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Dmitry Shchekochikhin, Olga Vinogradskaya, Evgeniia Bublik, Maria Shmyreva, Gregory Koroba, Alexander Farmanov, Irakliy Aslanidis, Diana Pursanova, Veronica Manukova, Alexey Zilov, Alexey Zhivov
Materialtyp: Artikel
Språk:English
Publicerad: MDPI AG 2023-08-01
Serie:Journal of Vascular Diseases
Ämnen:
bisphosphonate
osteoporosis
zoledronate
(giant cell arteritis) large vessel arteritis
side effect
adverse event
Länkar:https://www.mdpi.com/2813-2475/2/3/24

Internet

https://www.mdpi.com/2813-2475/2/3/24

Liknande verk